The FDA modifies rituximab prescribing information to stress risk of hepatitis B virus reactivation
Hydrocodone Bitartrate, Secukinumab, Varenicline Updates, Trials, Approvals
Plus, rheumatology drug news, safety updates
Decernotinib, Subcutaneous Methotrexate Drug Updates, Trials, Approvals
Plus, rheumatology drug news, safety updates
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
Congress Considers More Regulation for Manufacturers of Compounding Drugs
New legislation would place manufacturers of compounding drugs under FDA supervision. (posted July 22, 2013)
What You Need to Know About a Proposed Risk Evaluation and Mitigation Strategy Program for Opioid Analgesics
The U.S. Food and Drug Administration favors enacting a mandatory opioid-prescribing training program for dispensers of the extended-release and long-acting analgesics
- « Previous Page
- 1
- …
- 22
- 23
- 24
- 25
- 26
- 27
- Next Page »